Table 5.
Summary of treatment outputs calculated in the Cervical Precancer Planning Tool (CPPT) by treatment scenario (Uganda example)
| Women treated | Scenario 1 | Scenario 2 | Scenario 3 | Scenario 4 | Scenario 5 |
|---|---|---|---|---|---|
| Number of screen positive women treated per year (total) | 10,702 | 8,324 | 7,135 | 6,600 | 9,513 |
| Number of women treated per year (HIV- or unknown) | 8,006 | 6,227 | 5,338 | 4,938 | 7,117 |
| Number of women treated per year (HIV +) | 2,696 | 2,097 | 1,797 | 1,662 | 2,396 |
| Treatment devices | |||||
| Total number of devices | 1,624 | 345 | 112 | 57 | 11 |
| Gas cryotherapya | 386 | 82 | 27 | 14 | 3 |
| Non-gas thermal ablationa | 1,238 | 263 | 85 | 43 | 9 |
| Equipment utilization (treatments per device per year) | 7 | 24 | 64 | 116 | 832 |
| Equipment utilizationb ((percentage utilized) per device per year) | 1% | 2% | 6% | 11% | 80% |
Scenarios for deploying treatment devices and (% of eligible women who receive treatment): 1: Screen and treat (90%); 2: Hospital (70%); 3: District (60%); 4: District clustering (50%); 5: Hybrid static-mobile (80%)
aAssumes 24% gas cryotherapy and 76% thermal ablation devices based on urbanization data in Uganda
bBased on 1,040 treatments per device per year